loadpatents
name:-0.071211099624634
name:-0.043421983718872
name:-0.015645980834961
Altenbach; Robert J. Patent Filings

Altenbach; Robert J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Altenbach; Robert J..The latest application filed is for "modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use".

Company Profile
17.42.52
  • Altenbach; Robert J. - Chicago IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20210238159 - Altenbach; Robert J. ;   et al.
2021-08-05
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,988,454 - Altenbach , et al. April 27, 2
2021-04-27
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,981,890 - Altenbach , et al. April 20, 2
2021-04-20
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,844,041 - Altenbach , et al. November 24, 2
2020-11-24
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,844,042 - Altenbach , et al. November 24, 2
2020-11-24
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,829,473 - Altenbach , et al. November 10, 2
2020-11-10
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20200277273 - Altenbach; Robert J. ;   et al.
2020-09-03
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20200277274 - Altenbach; Robert J. ;   et al.
2020-09-03
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20200277276 - Altenbach; Robert J. ;   et al.
2020-09-03
Modulators Of The Cystic Fibrosis Transmembrane Conductance Regulator Protein And Methods Of Use
App 20200277275 - Altenbach; Robert J. ;   et al.
2020-09-03
Heteroaryl substituted pyridines and methods of use
Grant 10,604,515 - Altenbach , et al.
2020-03-31
Substituted Pyrrolidines and Methods of Use
App 20190315687 - Altenbach; Robert J. ;   et al.
2019-10-17
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
Grant 10,428,017 - Altenbach , et al. October 1, 2
2019-10-01
Substituted pyrrolidines and methods of use
Grant 10,399,940 - Altenbach , et al. Sep
2019-09-03
Substituted Tricyclics and Method of Use
App 20190135827 - Altenbach; Robert J. ;   et al.
2019-05-09
Substituted Chromanes and Method of Use
App 20190127356 - Altenbach; Robert J. ;   et al.
2019-05-02
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20190077784 - Altenbach; Robert J. ;   et al.
2019-03-14
Heteroaryl Substituted Pyridines and Methods of Use
App 20190055229 - Altenbach; Robert J. ;   et al.
2019-02-21
Heteroaryl substituted pyridines and methods of use
Grant 10,138,227 - Altenbach , et al. Nov
2018-11-27
Modulators of cystic fibrosis transmembrane conductance regulator protein
Grant 10,118,916 - Altenbach , et al. November 6, 2
2018-11-06
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20180244611 - Altenbach; Robert J. ;   et al.
2018-08-30
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
App 20180244640 - Altenbach; Robert J. ;   et al.
2018-08-30
Substituted pyridines and method of use
Grant 10,047,051 - Altenbach , et al. August 14, 2
2018-08-14
Substituted pyrrolidines and methods of use
Grant 9,981,910 - Altenbach , et al. May 29, 2
2018-05-29
Substituted Pyrrolidines and Methods of Use
App 20180099931 - Altenbach; Robert J. ;   et al.
2018-04-12
Substituted Pyrrolidines and Methods of Use
App 20180099932 - Altenbach; Robert J. ;   et al.
2018-04-12
Substituted Tricyclics and Method of Use
App 20180037587 - Altenbach; Robert J. ;   et al.
2018-02-08
Substituted tricyclics and method of use
Grant 9,840,513 - Altenbach , et al. December 12, 2
2017-12-12
Heteroaryl Substituted Pyridines And Methods Of Use
App 20170349576 - Altenbach; Robert J. ;   et al.
2017-12-07
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator Protein
App 20170305891 - Altenbach; Robert J. ;   et al.
2017-10-26
Furo-3-carboxamide derivatives and methods of use
Grant 9,777,020 - Altenbach , et al. October 3, 2
2017-10-03
Substituted Chromanes And Method Of Use
App 20170190693 - Altenbach; Robert J. ;   et al.
2017-07-06
Substituted chromanes and method of use
Grant 9,642,831 - Altenbach , et al. May 9, 2
2017-05-09
Substituted Tricyclics And Method Of Use
App 20170015675 - Altenbach; Robert J. ;   et al.
2017-01-19
Substituted Pyridines And Method Of Use
App 20160355480 - Altenbach; Robert J. ;   et al.
2016-12-08
Substituted Chromanes And Method Of Use
App 20160120841 - Kym; Philip R. ;   et al.
2016-05-05
Furo-3-carboxamide Derivatives And Methods Of Use
App 20150210720 - Altenbach; Robert J. ;   et al.
2015-07-30
Macrocyclic benzofused pyrimidine derivatives
Grant 8,735,411 - Altenbach , et al. May 27, 2
2014-05-27
Benzothiazole and benzooxazole derivatives and methods of use
Grant 8,580,968 - Black , et al. November 12, 2
2013-11-12
Heteroaryl-fused macrocyclic pyrimidine derivatives
Grant 8,546,410 - Liu , et al. October 1, 2
2013-10-01
Macrocyclic pyrimidine derivatives
Grant 8,436,005 - Liu , et al. May 7, 2
2013-05-07
Substituted pyrimidine derivatives
Grant 8,278,311 - Liu , et al. October 2, 2
2012-10-02
Bicyclic-substituted amines as histamine-3 receptor ligands
Grant 8,273,767 - Altenbach , et al. September 25, 2
2012-09-25
Amino heterocyclic linked pyrimidine derivatives
Grant 8,268,846 - Wakefield , et al. September 18, 2
2012-09-18
Benzothiazole And Benzooxazole Derivatives And Methods Of Use
App 20120164070 - Black; Lawrence A. ;   et al.
2012-06-28
Fused Bicyclic-Substituted Amines as Histamine-3 Receptor Ligands
App 20120108637 - COWART; Marlon D. ;   et al.
2012-05-03
Benzothiazole and benzooxazole derivatives and methods of use
Grant 8,153,813 - Black , et al. April 10, 2
2012-04-10
Fused bicyclic-substituted amines as histamine-3 receptor ligands
Grant 8,106,088 - Cowart , et al. January 31, 2
2012-01-31
Method for pain treatment
Grant 7,985,745 - Cowart , et al. July 26, 2
2011-07-26
Bicyclic-substituted Amines As Histamine-3 Receptor Ligands
App 20110098285 - Altenbach; Robert J. ;   et al.
2011-04-28
Fused Bicyclic-substituted Amines As Histamine-3 Receptor Ligands
App 20100298291 - Cowart; Marlon D. ;   et al.
2010-11-25
Fused bicyclic-substituted amines as histamine-3 receptor ligands
Grant 7,807,697 - Cowart , et al. October 5, 2
2010-10-05
Amino Heterocyclic Linked Pyrimidine Derivatives
App 20100016344 - Wakefield; Brian D. ;   et al.
2010-01-21
Heteroaryl-fused Macrocyclic Pyrimidine Derivatives
App 20100004256 - Liu; Huaqing ;   et al.
2010-01-07
Substituted Pyrimidine Derivatives
App 20090270364 - Liu; Huaqing ;   et al.
2009-10-29
Macrocyclic Pyrimidine Derivatives
App 20090253678 - Liu; Huaqing ;   et al.
2009-10-08
Benzothiazole And Benzooxazole Derivatives And Methods Of Use
App 20090163464 - Black; Lawrence A. ;   et al.
2009-06-25
Bicyclic-substituted Amines As Histamine-3 Receptor Ligands
App 20090054420 - Altenbach; Robert J. ;   et al.
2009-02-26
Bicyclic-substituted amines as histamine-3 receptor ligands
Grant 7,456,196 - Altenbach , et al. November 25, 2
2008-11-25
Method for Pain Treatment
App 20080194538 - Cowart; Marlon D. ;   et al.
2008-08-14
Macrocyclic Benzofused Pyrimidine Derivatives
App 20080188452 - Altenbach; Robert J. ;   et al.
2008-08-07
Fused Bicyclic-substituted Amines As Histamine-3 Receptor Ligands
App 20080119520 - Cowart; Marlon D. ;   et al.
2008-05-22
Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
Grant 7,205,316 - Altenbach , et al. April 17, 2
2007-04-17
Bicyclic-substituted amines as histamine-3 receptor ligands
Grant 7,153,889 - Altenbach , et al. December 26, 2
2006-12-26
Bicyclic-substituted amines as histamine-3 receptor ligands
App 20060194798 - Altenbach; Robert J. ;   et al.
2006-08-31
Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
Grant 7,098,222 - Altenbach , et al. August 29, 2
2006-08-29
Fused bicyclic-substituted amines as histamine-3 receptor ligands
Grant 7,094,790 - Cowart , et al. August 22, 2
2006-08-22
Fused bicyclic-substituted amines as histamine-3 receptor ligands
App 20060142325 - Cowart; Marlon D. ;   et al.
2006-06-29
Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
App 20050272736 - Altenbach, Robert J. ;   et al.
2005-12-08
Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
App 20050272728 - Altenbach, Robert J. ;   et al.
2005-12-08
Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
App 20050256118 - Altenbach, Robert J. ;   et al.
2005-11-17
Tri-and bi-cyclic heteroaryl histamine-3 receptor ligands
App 20050256309 - Altenbach, Robert J. ;   et al.
2005-11-17
Fused bicyclic-substituted amines as histamine-3 receptor ligands
App 20040248899 - Cowart, Marlon D. ;   et al.
2004-12-09
Fused bicyclic-substituted amines as histamine-3 receptor ligands
App 20040224953 - Cowart, Marlon D. ;   et al.
2004-11-11
Fused bicyclic-substituted amines as histamine-3 receptor ligands
App 20040224952 - Cowart, Marlon D. ;   et al.
2004-11-11
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
Grant 6,780,872 - Drizin , et al. August 24, 2
2004-08-24
Bicyclic-substituted amines as histamine-3 receptor ligands
App 20040152704 - Altenbach, Robert J. ;   et al.
2004-08-05
Bicyclic-substituted amines as histamine-3 receptor ligands
App 20040092521 - Altenbach, Robert J. ;   et al.
2004-05-13
Potassium channel openers
Grant 6,645,968 - Altenbach , et al. November 11, 2
2003-11-11
Pyrano, piperidino, and thiopyrano compounds and methods of use
Grant 6,642,222 - Carroll , et al. November 4, 2
2003-11-04
Radioligands and their use for identifying potassium channel modulators
Grant 6,632,418 - Altenbach , et al. October 14, 2
2003-10-14
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
App 20030171394 - Drizin, Irene ;   et al.
2003-09-11
4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use
App 20030073850 - Altenbach, Robert J. ;   et al.
2003-04-17
Novel radioligands and their use for identifying potassium channel modulators
App 20030065182 - Altenbach, Robert J. ;   et al.
2003-04-03
Pyrano piperidino and thiopyrano compounds and methods of use
App 20030055035 - Carroll, Willilam A. ;   et al.
2003-03-20
Potassium channel openers
App 20020028836 - Altenbach, Robert J. ;   et al.
2002-03-07
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
App 20020007059 - Drizin, Irene ;   et al.
2002-01-17
Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adrenergic compounds
Grant 6,046,207 - Meyer , et al. April 4, 2
2000-04-04
Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adenergic compounds
Grant 5,891,882 - Meyer , et al. April 6, 1
1999-04-06
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
Grant 5,597,823 - Meyer , et al. January 28, 1
1997-01-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed